BioCryst Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This webpage of BioCryst Pharmaceuticals Inc was prepared by All Street Sevva using advanced Cognitive Robots. The Disclosure score covers 17 UN SDGs including: 'Clean Water & Sanitation', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'. This webpage contains a questions and answers table about BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 3.4, social score of 5.0 and governance score of 7.0.
5.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 886 | Veracyte Inc | 5.4 | High |
| 886 | Xlife Sciences AG | 5.4 | High |
| 912 | BioCryst Pharmaceuticals Inc | 5.3 | High |
| 912 | Acer Therapeutics Inc | 5.3 | High |
| 912 | Alembic Pharmaceuticals Ltd | 5.3 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does BioCryst Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid BioCryst Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas BioCryst Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs BioCryst Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes BioCryst Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes BioCryst Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for BioCryst Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.